Hafez Ismaili M'hamdi, Sanne van der Hout, Angus Clark, Guido de Wert
{"title":"Facing suffering honestly: On severity, utility, and the public good in reproductive genetic carrier screening.","authors":"Hafez Ismaili M'hamdi, Sanne van der Hout, Angus Clark, Guido de Wert","doi":"10.1038/s41431-026-02123-9","DOIUrl":null,"url":null,"abstract":"<p><p>Reproductive genetic carrier screening (RGCS) raises the question of which conditions should be included. Severity has long been the guiding criterion: conditions causing serious suffering, justify offering reproductive options. Some propose replacing severity with utility, defined as the usefulness of information for reproductive decision-making. Proponents of this approach claim that utility aligns more directly with RGCS's aim of supporting informed choice while avoiding stigmatizing judgments about genetic conditions. This article challenges that proposal. First, utility depends on severity: contextual factors such as preimplantation genetic testing become relevant only once a condition is judged sufficiently severe. Second, while severity retains some clinical anchors such as prognosis, functional limitations, treatment burden, utility dissolves into subjective preferences, making it ill-suited for guiding population-level policy. Third, collective recognition of severity provides prospective parents with a moral frame of reference that eases the heavy responsibility of reproductive decisions. Fourth, avoiding severity judgments in the name of respect risks both invalidating the suffering of affected individuals and bypassing the democratic deliberation essential to public healthcare policy. We argue that value judgments in RGCS are inevitable and necessary. Severity, though imperfect, provides the shared normative anchor needed for publicly funded programs. Facing suffering honestly, acknowledging severity while respecting those who live with severe conditions, is the foundation of a compassionate and democratic RGCS policy.</p>","PeriodicalId":12016,"journal":{"name":"European Journal of Human Genetics","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Human Genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41431-026-02123-9","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Reproductive genetic carrier screening (RGCS) raises the question of which conditions should be included. Severity has long been the guiding criterion: conditions causing serious suffering, justify offering reproductive options. Some propose replacing severity with utility, defined as the usefulness of information for reproductive decision-making. Proponents of this approach claim that utility aligns more directly with RGCS's aim of supporting informed choice while avoiding stigmatizing judgments about genetic conditions. This article challenges that proposal. First, utility depends on severity: contextual factors such as preimplantation genetic testing become relevant only once a condition is judged sufficiently severe. Second, while severity retains some clinical anchors such as prognosis, functional limitations, treatment burden, utility dissolves into subjective preferences, making it ill-suited for guiding population-level policy. Third, collective recognition of severity provides prospective parents with a moral frame of reference that eases the heavy responsibility of reproductive decisions. Fourth, avoiding severity judgments in the name of respect risks both invalidating the suffering of affected individuals and bypassing the democratic deliberation essential to public healthcare policy. We argue that value judgments in RGCS are inevitable and necessary. Severity, though imperfect, provides the shared normative anchor needed for publicly funded programs. Facing suffering honestly, acknowledging severity while respecting those who live with severe conditions, is the foundation of a compassionate and democratic RGCS policy.
期刊介绍:
The European Journal of Human Genetics is the official journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports and reviews in the rapidly expanding field of human genetics and genomics. It covers molecular, clinical and cytogenetics, interfacing between advanced biomedical research and the clinician, and bridging the great diversity of facilities, resources and viewpoints in the genetics community.
Key areas include:
-Monogenic and multifactorial disorders
-Development and malformation
-Hereditary cancer
-Medical Genomics
-Gene mapping and functional studies
-Genotype-phenotype correlations
-Genetic variation and genome diversity
-Statistical and computational genetics
-Bioinformatics
-Advances in diagnostics
-Therapy and prevention
-Animal models
-Genetic services
-Community genetics